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Introduction: Surgery followed by adjuvant therapy represents the most adequate
treatment for advanced oral squamous cell carcinoma (OSCC). Free flaps are considered
the best reconstructive option after major oral surgery. In the last decades, OSCC has
increased in the elderly due to an augmented life span. The aim of this work is to evaluate
the feasibility of microvascular surgery in patients older than 75 years, focusing on clinical
and surgical prognosticators.
Methods: “Older old” (aged ≥ 75) and “oldest old” (>85) patients who underwent
microvascular reconstruction for OSCC from 2002 to 2018 were retrospectively
evaluated in three referral Head and Neck Departments. Demographic, clinical, and
surgical data were collected and analyzed. Pre-operative assessment was performed
by ASA and ACE-27 scores. Complications were grouped as medical or surgical, and
major or minor according to the Clavien-Dindo scale.
Results: Eighty-four patients (72 “older old” and 12 “oldest old”) were treated with a free
flap success rate of 94.1%. Thirty-seven (44.7%) and nine (10.7%) patients had minor
and major medical complications, respectively; 18 (21.4%) and 17 (20.2%) had minor
and major surgical complications, respectively. Twenty-one (25%) patients had both
medical and surgical complications (with a statistically significant association, p= 0.018).
Overall, 52 (61.9%) patients had at least one complication: ASA score, diabetes mellitus,
and duration of general anesthesia (DGA) significantly impacted the complication rate at
multivariate analysis.
Conclusion: Our data confirm the feasibility of free flaps for OSCC reconstruction
in appropriately selected elderly patients. Pre-operative assessment and aggressive
management of glycemia in patients with diabetes is mandatory. DGA should be reduced
as much as possible to prevent post-surgical complications. Comprehensive geriatric
assessment is of paramount importance in this subset of patients.
Keywords: oral cancer, elderly, free flaps, advanced age, medical complications, surgical complications, ACE27,
ASA
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INTRODUCTION
While therapeutic and survival improvements have been recently
reported for many head and neck cancers (HNC), oral squamous
cell carcinoma (OSCC) management has not demonstrated
substantial changes in the last decades and still remains
challenging for both patients and surgeons. The National
Comprehensive Cancer Network guidelines for advanced (Stages
III-IV) OSCC indicate surgery with adjuvant treatments as
the mainstay, whereas upfront radiotherapy (RT) or combined
chemoradiation (CRT) should be considered when surgery is not
feasible (1).
Epidemiological data projections from GLOBOCAN 2012
report that, among the 500,000 newly diagnosed cases in 2035,
almost a third will occur in the elderly (>65 year-old) (2). It
is a fact, indeed, that a major demographic shift is on the way,
especially in industrialized countries, since life expectancy is
increasing as the result of better prevention, medical, and surgical
treatment, and improvements in overall social and economic
status. This has led to a substantial increase of the proportion
of older individuals in relation to the general population and,
thus, to a redefinition of a proper cut-off for designation of the
elderly. The US National Institute of Aging establishes the lower
limit of elderly at 65 years and subdivides this cohort into three
subgroups: (1) 65–74 years defined as the “young old;” (2) 75–84
years or the “older old;” and (3) 85 years or more as the “oldest
old” (3).
In a retrospective review on HNC, 12% of patients were
found to be older than 70 years (4). Moreover, data from
different European centers have shown how 6–32% of HNC
patients are nowadays diagnosed between 70 and 75 years of
age (5, 6). According to these data, it is conceivable that, in the
next 20 years, major surgical procedures requiring composite
resections and some kind of reconstruction for OSCC will
be even more frequently addressed in an increasingly elderly
population, possibly with amore advanced comorbidity status. In
fact, since their introduction 30 years ago, microvascular flaps are
increasingly considered the first (and sometimes the only) choice
for reconstruction of complex head and neck defects, especially
in the oral cavity, due to their unique possibility to tailor the best
tissue to be harvested according to the surgical defect created,
reaching a success rate of 90–98% (7–9).
The aim of this study is to evaluate the feasibility and
outcomes of free flaps reconstruction during major surgical
procedures for OSCC in patients aged 75 years or more, focusing
on factors that can impact on the rate of complications.
MATERIALS AND METHODS
This multi-institutional retrospective study was conducted
in three Italian referral Head and Neck Departments: (1)
Otorhinolaryngology—Head and Neck Surgery of the University
of Brescia; (2) Otorhinolaryngology—Head and Neck Surgery
of the National Cancer Institute “Regina Elena” in Rome, and
(3) Otorhinolaryngology, Maxillofacial, and Thyroid Surgery
of the National Cancer Institute in Milan. It included OSCC
patients aged 75 years or more and treated between January
TABLE 1 | The Clavien-Dindo classification system for medical and surgical
complications.
Grade Description Number of
patients (%)
Grade 1 Any deviation from the normal post-operative
course not requiring surgical, endoscopic, or
radiological intervention. Allowed therapeutic
regimens are: drugs as anti-emetics, antipyretics,
analgesics, diuretics, electrolytes, and
physiotherapy. This grade also includes wound
infections opened at the bedside
39 (46.4)
Grade 2 Requiring pharmacological treatment with drugs
other than such allowed for Grade I
complications. Blood transfusions and total
parenteral nutrition are also included
12 (14.2)
Grade 3 Complications requiring surgical, endoscopic, or
radiological intervention. They are distinguished
into:
Grade 3a—intervention not under general
anesthetic
Grade 3b—intervention under general anesthetic
24 (28.5)
Grade 4 Life-threatening complications. This includes
central nervous system complications which
require intensive care. They are distinguished
into:
Grade 4a–single-organ dysfunction (including
dialysis)
Grade 4b–multi-organ dysfunction
5 (5.9)
Grade 5 Death 4 (4.7)
2002 and August 2018 by free flaps reconstruction after major
OSCC procedures.
Post-operative complications were analyzed and classified
according to the following criteria: (1) based on the subsequent
treatment strategy, each complication was named as surgical, if
it required a surgical solution, or medical, if suitable for non-
surgical management; (2) based on the severity, according to
the Clavien-Dindo scale (10), each complication was arbitrarily
categorized as minor (grade 1–3a) or major (grade 3b−5)
(Table 1). Therefore, four sets of possible clinical scenarios
were considered: minor surgical, major surgical, minor medical,
and major medical complications. The rate of each was
then calculated and association between medical and surgical
complication rates evaluated by the chi-squared test.
Demographic, clinical, and surgical data of patients, including
age, gender, body mass index (BMI), chronic comorbidities, pre-
and post-operative hematocrit (Hct), hemoglobin (Hb), albumin,
previous head, and neck treatments, tumor subsite and stage,
duration of general anesthesia (DGA), type of surgical defect,
type of free flap used, and flap outcome were collected. Moreover,
the American Society of Anesthesiologists (ASA) score (Table 2)
(11) and the 27-item adult comorbidity evaluation (ACE-27)
scale (12, 13) were retrieved for each patient (Table 3).
Once data were collected, the subgroups of “older old” and
“oldest old” were studied in order to compare outcomes.
Ethical committee approval was not deemed necessary due to
the retrospective nature of the study. Patients routinely signed
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TABLE 2 | Patient stratification according to the American Society of
Anesthesiologist (ASA) physical status classification system.
ASA Score Condition Number of
patients (%)
1 Healthy 0
2 Mild systemic disease 21 (25)
3 Severe systemic disease 56 (66.6)
4 Severe systemic disease which is a
constant threat to life
7 (8.3)
5 A moribund person who is not expected to
survive without the operation
0
6 A person declared brain-dead whose
organs are being removed for donor
purposes
0
TABLE 3 | Patient stratification according to the ACE-27 scoring system.
ACE-27 score Condition Number of patients (%)
0 No comorbidity 12 (14.2)
1 Mild comorbidity 20 (23.8)
2 Moderate comorbidity 45 (53.5)
3 Severe comorbidity 7 (8.3)
a form consenting to use of personal data for scientific and
research purposes before enrollment in any kind of diagnostic
and therapeutic pathway at all three institutions.
Statistical Analysis
A univariate analysis of factors potentially affecting the
complication rate was performed using demographic and
clinical information with the Mann-Whitney test for continuous
variables and the Chi-square or Fisher’s exact test for categorical
variables, as appropriate. Level of significance for selection of
predictors was set at 0.15. A multivariate logistic regression
analysis with overall rate of complications (dependent
variable) and factors applying significance at univariate analysis
(independent variables) was run to identify predictors that are
independently associated with an increased rate of complications.
The test was repeated for each type of complication with a level
of significance set at 0.05. P-values between 0.05 and 0.10 were
considered to be close-to-significance.
RESULTS
The study included 84 patients, 48 males, and 36 females. Mean
age was 79.9 years (median, 79; range, 75–90). Seventy-two
patients (85.7%) were considered “older old” and 12 (14.3%)
“oldest old.” Mean BMI was 24.6 m/kg2 (median, 25; range,
15.4–31.2). Eighteen (21.4%) patients had type two diabetes
mellitus (DM). Twenty-one (25%) had a recurrent tumor and
had previously received oncologic treatment (Table 4). All
patients underwent free flap reconstruction. Three required two
simultaneous free flaps (fibula and forearm in two, and fibula and
antero-lateral thigh in one) (Table 5).
TABLE 4 | Demographic and clinical data of the present series of patients.
Variable Category Value
Age (n) 75–85 72 (85.7%)
>85 12 (14.2%)
Gender (M/F) 48/36
BMI (m/kg2) Mean, 24.6; median, 25; range,
15.4–31.2
Comorbidities (%) Hypertension 53 (63%)
Hyperlipidemia 14 (16.6%)
Hepatic Disease 9 (10.7%)
Cardiac Disease 16 (19%)
Diabetes Mellitus 18 (21.4%)
Pulmonary Disease 12 (14.2%)
Peripheral Vascular Disease 5 (5.9%)
Renal Insufficiency 8 (9.5%)
Hematocrit (%) Pre-operative Mean, 40.59 (range,
31.10–50.90)
Post-operative Mean, 33.14 (range,
42.60–22.70)
Hemoglobin (g/dl) Pre-operative Mean, 13.36 (range, 9.7–16.9)
Post-operative Mean, 10.99 (range, 7.9–13.8)
Albumin (g/dl) Mean, 4.05 (range, 3.14–5.01)
Previous RT (%) 12/84 (14.2%)
Smoking (%) 32/84 (38%)
Alcohol (%) 40/84 (47.6%)
DGA (minutes) Mean, 553.5 (range, 230–890)
Patients requiring blood transfusion (%) 33/84 (39.2%)
The flap success rate was 94.1%: complete necrosis was
observed in five patients (two arterial and three venous
insufficiencies). No rescue microvascular revision was possible
and/or successful. These patients were therefore, secondarily
rescued as follows: one with Bernard-Von Burrow local flap, two
by pedicled pectoralis major flap, one with a further antero-lateral
thigh, and one with an obturator prosthesis. Partial flap necrosis
was observed in four (4.7%) patients; of these, three received
additional surgical interventions (two pedicled pectoralis major
flap and one abdominal fat graft for salivary fistula/cervical suture
dehiscence), and one conservative non-surgical intervention.
Perioperative deaths occurred in four cases (4.8%), all secondary
to septic shock with multi-organ failure.
Mean hospitalization time was 23.7 days (range, 8–131). Mean
time for tracheotomy and naso-gastric feeding tube removal was
10.4 (range, 3–40) and 16.4 days (range, 2–41), respectively. The
majority of patients were categorized as ASA 3 or 4 (75%) or
ACE-27 score 2 or 3 (61.9%). While 75% of patients presented
a grade 1–3a complication according to the Clavien-Dindo scale,
25% presented a complication grade 3b or higher, thus requiring
some kind of intervention.
Overall Complications Rate
Overall, 52 (61.9%) patients had at least one complication.
Factors eligible for multivariate analysis were: age, DM, post-
operative Hb, post-operative Hct, and DGA. At multivariate
analysis, DM and DGA were statistically significant (Table 6 and
Figures 1A–C). Twenty-one (25%) patients experienced both
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TABLE 5 | TNM staging and surgical data of the present series of patients.
Variable Category Number of patients (%)
T 1 2 (2.3)
2 14 (16.6)
3 22 (26.1)
4 46 (54.7)
N 0 48 (57.1)
1 11 (13)
2 19 (22.6)
3 6 (7.1)
Tumor site of origin Tongue 33 (39.3)
Buccal mucosa 14 (16.7)
Floor of mouth 15 (17.8)
Lower gum 9 (10.8)
Retromolar trigone 7 (8.3)
Hard palate + upper gum 6 (7.1)
Type of surgical defect Soft tissues only 56 (66.7)
Soft tissues and bone 28 (33.3)
Free flap used* Radial forearm 41 (48.8)
ALT 31 (36.9)
LD 5 (5.9)
Fibula 6 (7.1)
Scapula 3 (3.5)
Rectus abdominis 1 (1.1)
*Multiple flaps were used for reconstruction in three cases.
medical and surgical complications. Such association turned out
to be statistically significant (p= 0.018) at the chi-squared test. As
a matter of fact, 52.5% of patients presenting at least one medical
complication showed also a surgical one, while those without
medical complications presented surgical issues in 27.3% of cases.
Minor Medical Complications Rate
Thirty-seven (44%) patients had minor medical complications
(Table 6). Factors eligible for multivariate analysis were: age,
post-operative Hb, post-operative Hct, and DGA. The latter
was the only factor with a statistical significance at multivariate
analysis (Table 6 and Figure 2).
Major Medical Complications Rate
Nine (10.7%) patients had major medical complications
(Table 6). Previous RT, smoking habit, and ASA category were
the factors considered eligible for multivariate analysis. History
of previous RT was independently associated with the probability
of major medical complications at multivariate analysis. Smoking
and ASA four category showed close-to-significance p-values
(Table 6 and Figure 3).
Minor Surgical Complications Rate
Eighteen (21.4%) patients had minor surgical complications
(Table 6). Factors eligible for multivariate analysis were: age,
pT category, nodal status, and pre-operative Hb. None of these
factors were significantly associated with the rate of minor
TABLE 6 | Major and minor complications.
Minor medical complications Number of patients (%)
Cardiovascular 11 (13)
Tracheal/bronchopulmonary 16 (19)
Hepatic/pancreatic/gastroenteric 4 (5)
Electrolytic disorders 10 (12)
Nutritional deficiency 3 (4)
Post-operative delirium 3 (4)
Major medical complications
Cardiovascular 3 (4)
Tracheal/bronchopulmonary 4 (5)
Gastroenteric 1 (1)
Sepsis 2 (2)
Cerebral ischemia 1 (1)
Minor surgical complications
Cervical hematoma 3 (4)
Donor site hematoma 1 (5)
Flap venous congestion 2 (2)
Flap suture dehiscence 7 (8)
Cervical suture dehiscence 2 (2)
Donor site dehiscence 2 (2)
Chylous leak 2 (2)
Major surgical complications
Hemorrhage 2 (2)
Flap necrosis 9 (11)
Mandibular plate exposure 2 (2)
Fistula 3 (4)
surgical complications at multivariate analysis; however, nodal
status was close-to-significant (Table 6).
Major Surgical Complications Rate
Seventeen (20.2%) patients had major surgical complications
(Table 6). Age, DM, tumor subsite, and type of surgical
defect (bony vs. soft tissues only) were considered eligible
for multivariate analysis. Age and type of defect resulted
close-to-significant as potential predictors at multivariate
analysis (Table 7).
DISCUSSION
Life expectancy is increasing worldwide, and at a faster pace in
the developing countries, not only due to improved medical and
surgical treatments, but mostly for the progressively ameliorating
overall social and economic status. This has led to an increase of
the percentage of elderly people in the general population, thus
resulting in an imbalance between advanced age individuals and
their younger counterpart (14–17). In the past, the elderly were
generally considered as frail subjects based on “chronological”
age, and thereforemajor surgical treatments weremostly avoided.
Recently, the awareness that “chronological” age does not reliably
mirror “biological” age has emerged, thus leading to a consequent
reassessment of the decision-making process in this cohort of
patients (18).
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FIGURE 1 | (A) Relationship between overall complication rate and duration of
general anesthesia (DGA); (B) overall complication rates in diabetic and
non-diabetic patients; (C) overall complications rate and DGA in diabetic and
non-diabetic patients.
Moreover, despite considerable improvements in therapeutic
approaches and survival in HNC, 5-year overall survival for
OSCC still ranges between 50 and 60% and has not substantially
changed in the last decade (19–21). The mainstay of treatment
for these tumors is upfront surgery followed by adjuvant (C)RT
for advanced stages, with sound reconstruction procedures being
often required to guarantee important functions such as speech
and swallowing. Nowadays, free flaps are considered the best
reconstructive option to restore oral cavity morphological and
functional properties for two main reasons: (1) the wide range
of possibilities they offer to tailor the site, type, and size of
donor tissues according to the characteristics of the recipient site,
and (2) the availability of highly vascularized tissues, which are
frequently less involved by atherosclerotic changes, in order to
speed up the healing process, especially in unfavorable conditions
such as a post-actinic setting or adverse chemical conditions
due to direct and massive saliva exposure. Furthermore, some
complications (e.g., salivary fistula and serious bleeding) can lead
to dismal outcomes, considerably lengthening the post-operative
course, and should be therefore, prevented by liberal use of the
most appropriate reconstructive techniques (22).
Based on these premises, there is a growing need to collect
data on elderly HNC patients undergoing complex surgical
procedures. Indeed, several papers on the use of free flaps for
HNC in the elderly population have been published during
the last 10 years. All conclude that advanced age is not a
contraindication per se to microvascular reconstruction, and
surgical outcomes in this subset of patients are comparable to
those in the younger population, even though an increased rate
of medical complications can be reasonably expected (23–28).
The aim of this multi-institutional study was to measure
outcomes and shed light on some possible risk factors affecting
elderly patients receiving free flap reconstruction for purely
OSCC ablation. In our series, more than 60% of patients
experienced at least one complication, and DM and DGA
were found to be the most important factors affecting this
event at multivariate analysis. In particular, DM affected
21.4% of our patients and, surprisingly, our findings showed
that non-diabetic patients presented a higher rate of overall
complications compared to their diabetic counterparts (68.2
vs. 38.9%). On the basis of well-known physiopathological
concepts, it is generally accepted that DM has a negative
impact on free flap reconstruction due to its detrimental
effect on blood microcirculation (29). Recently, Liu et al. (30)
published their experience comparing 105 diabetic to 204 non-
diabetic patients (≥60 years of age) who underwent free flap
reconstruction for OSCC. Their findings showed an overall
incidence of flap complications of 24.3% (41.9% in diabetic
vs. 15.2% in non-diabetic with an odds-ratio [OR] of 3.413, p
≤ 0.001) and 13.9% of major complications requiring surgical
procedures (22.9% in diabetic vs. 9.3% in non-diabetic; p
≤ 0.001). Interestingly, vessel thrombosis (especially of the
vein) occurred with a higher percentage in the diabetic group,
particularly within the first 4 days after surgery (30). Other
studies assessing the association of DM with the rate of
complications and flap outcomes have reported controversial
results, thus preventing firm conclusions (31–36). Interestingly,
DM was mostly associated with flap-related complications (i.e.,
flap necrosis, fistula, dehiscence, wound infection) (30, 35–
37) whereas rarely with systemic problems (33) which are,
instead, highly represented in the present series. Moreover, the
paradoxical role of DM observed in the present series might be
due to the specific perioperative protocol that was delivered to
diabetic patients at our Institutes. In fact, all patients with DM
were comprehensively evaluated by Internal Medicine Unit staff
with the following aims: (1) to prescribe tailored perioperative,
continued intravenous administration of 5% glucose solution,
KCl, and short- and long-acting insulin (adjusted based on
periodic measurement of the capillary glucose), and (2) to
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FIGURE 2 | Correlation between minor medical complications and DGA.
FIGURE 3 | Factors affecting the rate of major medical complications.
assess and correct metabolic alterations typically found in such
patients. This protocol might have kept patients adequately
hydrated and with pre-operative glucose blood level in a normal
range. In fact, a recent paper from Bollig et al. demonstrated
that perioperative hyperglycemia is a common finding and
is significantly associated with the overall complications rate
regardless of previous DM history and management (38). This
piece of evidence aligns with our findings, suggesting that
in patients receiving microvascular reconstruction after OSCC
ablation adequate control of perioperative glycemia can have a
positive impact on the risk of complications counterbalancing the
negative effects of a diagnosis of DM.
Duration of general anesthesia was an important variable in
predicting complications and outcomes in this subset of patients.
Our results showed that >500min of DGA was associated with
more overall and minor medical complications (480 vs. 598min,
p < 0.001 and 494 vs. 629min; p < 0.001, respectively). This
relationship was also observed by Moorthy et al. who showed
that DGA had a significantly negative impact on both the rate
of complications (p < 0.006) and length of hospitalization (p <
0.001) in a series of 157 patients (≥65 years of age) surgically
treated for HNC. These data reinforce the belief that a double-
team approach, when feasible, is a wise option to reduce the
length of surgery, especially in elderly HNC patients (39).
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TABLE 7 | Results of multivariate analysis of factors independently predicting the probability of overall, minor medical, major medical, minor surgical, and major surgical
complications.
Complication Variable Complications rate Univariate p-value Multivariate p-value OR (95% CI)
Overall DM Non-diabetic pts: 68.2%
Diabetic pts: 38.9%
0.023† 0.043** 0.304 (0.096–0.963)
Overall DGA Pts without complications: 480min
Pts with complications: 598min
0.001* 0.002** 1.006 (1.002–1.009)
Minor medical DGA Pts without complications: 494min
Pts with complications: 629min
0.001* 0.0004** 1.008 (1.004–1.013)
Major medical Previous RT No previous RT: 8.3%
Previous RT: 25%
0.121‡ 0.021** 9.253 (1.394–61.427)
Major medical Smoking habit Non-smokers: 5.9%
Smokers: 18.2%
0.145‡ 0.058** 6.146 (0.942–40.075)
Major medical ASA category ASA 1–3: 7.8%
ASA 4: 42.9%
0.010‡ 0.052** 25.574 (0.972–672.920)
Minor surgical Nodal status N0: 14.9%
N+: 30.6%
0.086† 0.055** 2.997 (0.978–9.187)
Major surgical Age Pts without complications: 80.3 years
Pts with complications: 78.3 years
0.047* 0.096** 0.877 (0.752–1.024)
Major surgical Type of defect Soft tissues only: 14.3%
Soft tissues and bone: 32.1%
0.055† 0.071** 2.794 (0.916–8.525)
CI, Confidence interval; OR, Odds ratio. *Mann-Whitney test. **Logistic regression test.
†
Chi-square test. ‡Fisher’s exact test. Bold values are for statistical significant values.
Comorbidity assessment is crucial in the elderly and may
predict both outcomes and possible complications. In our study,
comorbidities were assessed through two different classifications:
ASA and ACE-27 scores. The first is used worldwide to define
the anesthesiology/surgical risk by virtue of its reliability and
simple rating system, while the second is a more complex score
based on 27 items assessing several aspects. Our findings, as
expected, showed that the large majority of patients presented
moderate/severe comorbidity status after evaluation by both ASA
and ACE-27 scores. Moreover, the ASA predicted major medical
complications with close to significance p-value at multivariate
analysis. These data are similar to those present in the literature,
confirming that high ASA scores in the elderly predict an
increased risk of medical complications, without affecting either
flap outcomes or perioperative mortality (23–25, 40). The main
drawback concerning ASA is its non-negligible inter-observer
variability that can potentially lead to important assessment
biases (41). On the other hand, ACE-27 did not affect any of the
outcomes considered in the present study. This is possibly due
to the complexity of this scale and the relatively small number
of patients considered herein. In fact, Hwang et al. recently
concluded that high ACE-27 and ASA scores have very similar
predictability on flap survival in the elderly (OR 5.854 and 4.397,
respectively; p < 0.05) (42).
Interestingly, our data did not show any statistical difference
in patients aged >85 years (“oldest old”) from the 75–
85 year-old counterparts (“older old”). This confirms data
published in the literature demonstrating that chronological
age by itself can be a confounder in clinical decision making
for planning treatment. However, the systematic use of a
comprehensive geriatric assessment to identify patients with a
high comorbidity status and advanced age (the “frail elderly”)
cannot be overemphasized.
In our series, pre-operative RT was found to significantly
affect the rate of major medical complications, with a 9-fold
increase at multivariate analysis. This is probably due to acute
and late toxicities, which can also affect organs that are non-
contiguous to the RT field (43). Although the effectiveness of
RT in elderly is undoubted (44, 45), Herle et al. published a
meta-analysis of 24 studies on the overall effects of (C)RT on
microvascular flaps, specifically focusing on its clinical impact
on reconstructive outcomes. The authors compared 2,842 free
flaps in irradiated vs. 3,491 in non-irradiated patients, and
found a significantly higher chance of flap failure (relative
risk [RR] 1.48, p = 0.003), flap complication (RR 1.84, p
< 0.001), and reoperation rate (RR 2.06, p < 0.001) in the
former, whereas no clear association with advanced age was
demonstrated (46).
CONCLUSIONS
Appropriate multidisciplinary treatment of the elderly is
unavoidably becoming a hot topic in the head and neck
oncology arena. In particular, advanced OSCC frequently
requires extensive surgical ablation followed by potentially
complex reconstructive procedures, for which free flaps are
gradually emerging as the first-choice option. Indeed, apart from
a number of considerations around the possibility to achieve
genuine oncological radicality, there is no sense in performing
such extensive resections in subjects with a presumed short
life expectancy if not trying to restore the best possible quality
of residual life. Therefore, adequate reconstructive technique
should be always aimed to restore speech and swallowing
while minimizing the risk of complications. On the other
hand, lengthy DGA and in-hospital stay should be carefully
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considered especially when dealing with advanced age patients.
However, our data herein confirm the safety, effectiveness, and
reproducibility of microsurgical free flaps in patients with >75
years of age treated for OSCC. Moreover, our results suggest
that DM should not be considered a risk factor per se in
this subset of patients; rather, the attention and perioperative
management should be oriented toward an optimal control of
perioperative glycemia. DGAwas confirmed to be a pivotal factor
in determining the overall rate of complications. Therefore,
surgical teams should be encouraged to reduce the duration
of surgery by operating with ablative and reconstruction teams
simultaneously. Finally, pre-operative comorbidity assessment
by ASA and ACE-27 is effective, but should be always
accompanied by mindful consideration of previous RT and
smoking history.
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